Karo Pharma’s guiding principle is to achieve positive growth in shareholder value. By having an open dialogue with current and potential shareholders, Karo Pharma strives to give the surrounding world a good insight into and an understanding of our business. In each interim report we describe the current status of all projects in the development portfolio and the operations in general.

18:01 - 15 Jan 2019

-0.13%, 37.7SEK, Vol: 2266479